Uma Mahadevan

Uma Mahadevan, MD currently serves as Professor of Medicine at UCSF, Director of the UCSF Center for Colitis and Crohn’s Disease, and Director of the IBD Fellowship. Certified by the American Board of Internal Medicine as a Diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she was Chair for the Clinical Immunology, Microbiology and Inflammatory Bowel Disease (IMIBD) Section and Chair of the AGA National IBD Parenthood initiative. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee. She was a Chair of the Crohn’s Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress in 2020. She will be the recipient of the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award. Dr. Mahadevan specializes in the treatment of ulcerative colitis and Crohn’s disease with a research focus in pregnancy and fertility in IBD, clinical trials of experimental therapy for IBD and dietary interventions. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and the SEAMUS diet study for UC. She has an interest in digital health and developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF. This IBD Chat can remotely monitor thousands of patients with IBD and integrate with the existing electronic health record.